OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Optimizing the use of partners for clinical trials depends on selecting the right contractor.
Demand for outsourced services of technical R&D activities is increasing.
Collaborative partnerships can foster success in formulation development projects.
April 02, 2022
The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.
Meeting patient needs and achieving high quality are common goals for all stakeholders.
The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.
April 01, 2022
Under the two-year task order, ATCC will continue to support the DCEG MEAS program in receiving, processing, storing, analyzing, and distributing clinical specimens from different cancer types.
March 18, 2022
Emmes has acquired Casimir, marking its fourth major acquisition.
March 02, 2022
Scientists can work to overcome the challenges associated with protein characterization through empowering technologies.
Continuous improvements in technologies and services will help cold chain operators meet future industry demand.
Capacity concerns and regulatory compliance considerations will drive the decision about outsourcing the manufacture of clinical trial materials.
February 23, 2022
Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.